VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q56807124  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000209.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q56807124‏
024 ‎‡a  0000-0003-4273-2261‏ ‎‡2  orcid‏
024 ‎‡a  7201411674‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q56807124‏
100 0 ‎‡a  Edward T Morgan‏ ‎‡9  es‏ ‎‡9  ast‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  এডওয়ার্ড টি মর্গান‏ ‎‡9  bn‏
400 0 ‎‡a  Edward T Morgan‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Edward T Morgan‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A non-lethal malarial infection results in reduced drug metabolizing enzyme expression and drug clearance in mice‏
670 ‎‡a  Author's A role for one or more p450 enzymes in the response to sepsis.‏
670 ‎‡a  Author's Alcohol oxidation by isozyme 3a of liver microsomal cytochrome P-450‏
670 ‎‡a  Author's Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes‏
670 ‎‡a  Author's Cancer, inflammation, and therapy: effects on cytochrome p450-mediated drug metabolism and implications for novel immunotherapeutic agents.‏
670 ‎‡a  Author's Catalytic activity of cytochrome P-450 isozyme 3a isolated from liver microsomes of ethanol-treated rabbits. Oxidation of alcohols‏
670 ‎‡a  Author's Changes in the rat hepatic mixed function oxidase system associated with chronic ethanol vapor inhalation‏
670 ‎‡a  Author's Characterization of CYP4A induction in rat liver by inflammatory stimuli: dependence on sex, strain, and inflammation-evoked hypophagia.‏
670 ‎‡a  Author's Comparison of six rabbit liver cytochrome P-450 isozymes in formation of a reactive metabolite of acetaminophen‏
670 ‎‡a  Author's Cytochromes P450 and flavin monooxygenases--targets and sources of nitric oxide.‏
670 ‎‡a  Author's Differences in glycogen, lipids, and enzymes in livers from rats flown on COSMOS 2044‏
670 ‎‡a  Author's Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression‏
670 ‎‡a  Author's Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Independence from the hypothalamo-pituitary axis‏
670 ‎‡a  Author's Down-regulation of phenobarbital-induced cytochrome P4502B mRNAs and proteins by endotoxin in mice: independence from nitric oxide production by inducible nitric oxide synthase‏
670 ‎‡a  Author's Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production‏
670 ‎‡a  Author's Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures.‏
670 ‎‡a  Author's Effects of bacterial lipopolysaccharide on phenobarbital-induced CYP2B expression in mice‏
670 ‎‡a  Author's Effects of cytochrome b5 on cytochrome P-450-catalyzed reactions. Studies with manganese-substituted cytochrome b5‏
670 ‎‡a  Author's Effects of early maternal separation on ethanol intake, GABA receptors and metabolizing enzymes in adult rats.‏
670 ‎‡a  Author's Effects of vanadate on hepatic cytochrome P-450 expression in streptozotocin-diabetic rats.‏
670 ‎‡a  Author's Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450.‏
670 ‎‡a  Author's Expression of UDP-glucuronosyltransferase isoform mRNAs during inflammation and infection in mouse liver and kidney‏
670 ‎‡a  Author's Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes.‏
670 ‎‡a  Author's Growth hormone-dependent and -independent regulation of cytochrome P-450 isozyme expression in streptozotocin-diabetic rats‏
670 ‎‡a  Author's Growth hormone regulates expression of rat liver cytochrome P-450 15 beta at a pretranslational level‏
670 ‎‡a  Author's Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice.‏
670 ‎‡a  Author's Hepatic cytochrome P450 regulation in disease states‏
670 ‎‡a  Author's Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection.‏
670 ‎‡a  Author's Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models.‏
670 ‎‡a  Author's Hormonal and developmental regulation of expression of the hepatic microsomal steroid 16 alpha-hydroxylase cytochrome P-450 apoprotein in the rat‏
670 ‎‡a  Author's Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics‏
670 ‎‡a  Author's Inflammatory prompts produce isoform-specific changes in the expression of leukotriene B‏
670 ‎‡a  Author's Inflammatory prompts produce isoform-specific changes in the expression of leukotriene B(4) omega-hydroxylases in rat liver and kidney.‏
670 ‎‡a  Author's Inhibition of estrogen-induced mammary tumor formation in MMTV-aromatase transgenic mice by 4-chlorophenylacetate.‏
670 ‎‡a  Author's Mechanisms of cytochrome P450 regulation by inflammatory mediators.‏
670 ‎‡a  Author's Metabolism and action of proteasome inhibitors in primary human hepatocytes‏
670 ‎‡a  Author's Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis‏
670 ‎‡a  Author's Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent‏
670 ‎‡a  Author's Modulation of drug metabolism in infectious and inflammatory diseases‏
670 ‎‡a  Author's Molecular cloning and regulation of expression of two novel mouse CYP4F genes: expression in peroxisome proliferator-activated receptor alpha-deficient mice upon lipopolysaccharide and clofibrate challenges‏
670 ‎‡a  Author's Nitric oxide and interleukin-1β stimulate the proteasome-independent degradation of the retinoic acid hydroxylase CYP2C22 in primary rat hepatocytes.‏
670 ‎‡a  Author's Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2‏
670 ‎‡a  Author's Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins‏
670 ‎‡a  Author's Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes‏
670 ‎‡a  Author's Nitric Oxide Mediated Degradation of CYP2A6 via the Ubiquitin-Proteasome Pathway in Human Hepatoma Cells‏
670 ‎‡a  Author's Oxidation of tricyclic antidepressant drugs, debrisoquine and 7-ethoxyresorufin, by human liver preparations‏
670 ‎‡a  Author's Physiological and pathophysiological regulation of cytochrome P450.‏
670 ‎‡a  Author's Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting‏
670 ‎‡a  Author's Preparation and characterization of monoclonal antibodies recognizing unique epitopes on sexually differentiated rat liver cytochrome P-450 isozymes‏
670 ‎‡a  Author's Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment‏
670 ‎‡a  Author's Pretranslational suppression of cytochrome P-450h‏
670 ‎‡a  Author's Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in rat liver after administration of interferon inducers‏
670 ‎‡a  Author's Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits‏
670 ‎‡a  Author's Purification, characterization, and pituitary regulation of the sex-specific cytochrome P-450 15 beta-hydroxylase from liver microsomes of untreated female rats.‏
670 ‎‡a  Author's Purification of a desmethylimipramine and debrisoquine hydroxylating cytochrome P-450 from human liver‏
670 ‎‡a  Author's Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin.‏
670 ‎‡a  Author's Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes‏
670 ‎‡a  Author's Regulation of cytochrome p450 by inflammatory mediators: why and how?‏
670 ‎‡a  Author's Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease‏
670 ‎‡a  Author's Regulation of cytochrome P450 expression by sphingolipids.‏
670 ‎‡a  Author's Regulation of cytochromes P450 during inflammation and infection.‏
670 ‎‡a  Author's Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer‏
670 ‎‡a  Author's Regulation of hepatic cytochrome P450 2C11 by glucocorticoids‏
670 ‎‡a  Author's Regulation of hepatic cytochrome P450 2C11 by transforming growth factor-beta, hepatocyte growth factor, and interleukin-11‏
670 ‎‡a  Author's Roles of nitric oxide in inflammatory downregulation of human cytochromes P450.‏
670 ‎‡a  Author's Selective and cytokine-dependent regulation of hepatic transporters and bile acid homeostasis during infectious colitis in mice‏
670 ‎‡a  Author's Selective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen‏
670 ‎‡a  Author's Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver‏
670 ‎‡a  Author's Selective suppression of rat hepatic cytochrome P450 2C11 by chloramphenicol‏
670 ‎‡a  Author's Sexual differentiation of cytochrome P-450 in rat liver. Evidence for a constitutive isozyme as the male-specific 16 alpha-hydroxylase.‏
670 ‎‡a  Author's Sphingolipid-dependent signaling in regulation of cytochrome P450 expression‏
670 ‎‡a  Author's Sphingomyelin hydrolysis and regulation of the expression of the gene for cytochrome P450.‏
670 ‎‡a  Author's Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin‏
670 ‎‡a  Author's Suppression of constitutive cytochrome P450 gene expression by epidermal growth factor receptor ligands in cultured rat hepatocytes‏
670 ‎‡a  Author's Suppression of rat hepatic microsomal cytochromes P450 by cyclophosphamide is correlated with plasma thyroid hormone levels and displays differential strain sensitivity.‏
670 ‎‡a  Author's Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in‏
670 ‎‡a  Author's The dose-response model for dioxin‏
670 ‎‡a  Author's The effect of adrenalectomy upon the absorption, distribution and metabolism of ethanol in the rat‏
670 ‎‡a  Author's The field of pharmacology and toxicology‏
670 ‎‡a  Author's The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice‏
670 ‎‡a  Author's TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease‏
670 ‎‡a  Author's Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals.‏
670 ‎‡a  Author's Tyrosine nitration contributes to nitric oxide-stimulated degradation of CYP2B6‏
909 ‎‡a  (orcid) 0000000342732261‏ ‎‡9  1‏
909 ‎‡a  (scopus) 7201411674‏ ‎‡9  1‏
919 ‎‡a  catalyticactivityofcytochromep450isozyme3aisolatedfromlivermicrosomesofethanoltreatedrabbitsoxidationofalcohols‏ ‎‡A  Catalytic activity of cytochrome P-450 isozyme 3a isolated from liver microsomes of ethanol-treated rabbits. Oxidation of alcohols‏ ‎‡9  1‏
919 ‎‡a  changesintherathepaticmixedfunctionoxidasesystemassociatedwithchronicethanolvaporinhalation‏ ‎‡A  Changes in the rat hepatic mixed function oxidase system associated with chronic ethanol vapor inhalation‏ ‎‡9  1‏
919 ‎‡a  tyrosinenitrationcontributestonitricoxidestimulateddegradationofcyp2b6‏ ‎‡A  Tyrosine nitration contributes to nitric oxide-stimulated degradation of CYP2B6‏ ‎‡9  1‏
919 ‎‡a  transcriptionalsuppressionofcytochromep450genesbyendogenousandexogenouschemicals‏ ‎‡A  Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals.‏ ‎‡9  1‏
919 ‎‡a  tlr4dependentandindependentregulationofhepaticcytochromep450inmicewithchemicallyinducedinflammatoryboweldisease‏ ‎‡A  TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease‏ ‎‡9  1‏
919 ‎‡a  receptortyrosinekinaseephb2promoteshepaticfibrosisinmice‏ ‎‡A  The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice‏ ‎‡9  1‏
919 ‎‡a  fieldofpharmacologyandtoxicology‏ ‎‡A  The field of pharmacology and toxicology‏ ‎‡9  1‏
919 ‎‡a  effectofadrenalectomyupontheabsorptiondistributionandmetabolismofethanolintherat‏ ‎‡A  The effect of adrenalectomy upon the absorption, distribution and metabolism of ethanol in the rat‏ ‎‡9  1‏
919 ‎‡a  doseresponsemodelfordioxin‏ ‎‡A  The dose-response model for dioxin‏ ‎‡9  1‏
919 ‎‡a  suppressionoftheconstitutiveexpressionofcytochromep4502c11bycytokinesandinterferonsinprimaryculturesofrathepatocytescomparisonwithinductionofacutephasegenesanddemonstrationthatcyp2c11promotersequencesareinvolvedin‏ ‎‡A  Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in‏ ‎‡9  1‏
919 ‎‡a  suppressionofrathepaticmicrosomalcytochromesp450bycyclophosphamideiscorrelatedwithplasmathyroidhormonelevelsanddisplaysdifferentialstrainsensitivity‏ ‎‡A  Suppression of rat hepatic microsomal cytochromes P450 by cyclophosphamide is correlated with plasma thyroid hormone levels and displays differential strain sensitivity.‏ ‎‡9  1‏
919 ‎‡a  suppressionofconstitutivecytochromep450geneexpressionbyepidermalgrowthfactorreceptorligandsinculturedrathepatocytes‏ ‎‡A  Suppression of constitutive cytochrome P450 gene expression by epidermal growth factor receptor ligands in cultured rat hepatocytes‏ ‎‡9  1‏
919 ‎‡a  suppressionofconstitutivecytochromep450geneexpressioninliversofratsundergoinganacutephaseresponsetoendotoxin‏ ‎‡A  Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin‏ ‎‡9  1‏
919 ‎‡a  sphingomyelinhydrolysisandregulationoftheexpressionofthegeneforcytochromep450‏ ‎‡A  Sphingomyelin hydrolysis and regulation of the expression of the gene for cytochrome P450.‏ ‎‡9  1‏
919 ‎‡a  sphingolipiddependentsignalinginregulationofcytochromep450expression‏ ‎‡A  Sphingolipid-dependent signaling in regulation of cytochrome P450 expression‏ ‎‡9  1‏
919 ‎‡a  sexualdifferentiationofcytochromep450inratliverevidenceforaconstitutiveisozymeasthemalespecific16alphahydroxylase‏ ‎‡A  Sexual differentiation of cytochrome P-450 in rat liver. Evidence for a constitutive isozyme as the male-specific 16 alpha-hydroxylase.‏ ‎‡9  1‏
919 ‎‡a  selectivesuppressionofrathepaticcytochromep4502c11bychloramphenicol‏ ‎‡A  Selective suppression of rat hepatic cytochrome P450 2C11 by chloramphenicol‏ ‎‡9  1‏
919 ‎‡a  selectivesuppressionofcytochromep450geneexpressionbyinterleukins1and6inratliver‏ ‎‡A  Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver‏ ‎‡9  1‏
919 ‎‡a  selectiverolefortumornecrosisfactorαbutnotinterleukin1orkupffercellsindownregulationofcyp3a11andcyp3a25inliversofmiceinfectedwithanoninvasiveintestinalpathogen‏ ‎‡A  Selective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen‏ ‎‡9  1‏
919 ‎‡a  selectiveandcytokinedependentregulationofhepatictransportersandbileacidhomeostasisduringinfectiouscolitisinmice‏ ‎‡A  Selective and cytokine-dependent regulation of hepatic transporters and bile acid homeostasis during infectious colitis in mice‏ ‎‡9  1‏
919 ‎‡a  rolesofnitricoxideininflammatorydownregulationofhumancytochromesp450‏ ‎‡A  Roles of nitric oxide in inflammatory downregulation of human cytochromes P450.‏ ‎‡9  1‏
919 ‎‡a  regulationofhepaticcytochromep4502c11bytransforminggrowthfactorbetahepatocytegrowthfactorandinterleukin11‏ ‎‡A  Regulation of hepatic cytochrome P450 2C11 by transforming growth factor-beta, hepatocyte growth factor, and interleukin-11‏ ‎‡9  1‏
919 ‎‡a  regulationofhepaticcytochromep4502c11byglucocorticoids‏ ‎‡A  Regulation of hepatic cytochrome P450 2C11 by glucocorticoids‏ ‎‡9  1‏
919 ‎‡a  regulationofdrugmetabolizingenzymesandtransportersininfectioninflammationandcancer‏ ‎‡A  Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer‏ ‎‡9  1‏
919 ‎‡a  regulationofcytochromesp450duringinflammationandinfection‏ ‎‡A  Regulation of cytochromes P450 during inflammation and infection.‏ ‎‡9  1‏
919 ‎‡a  regulationofcytochromep450expressionbysphingolipids‏ ‎‡A  Regulation of cytochrome P450 expression by sphingolipids.‏ ‎‡9  1‏
919 ‎‡a  regulationofcytochromep450enzymeactivityandexpressionbynitricoxideinthecontextofinflammatorydisease‏ ‎‡A  Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease‏ ‎‡9  1‏
919 ‎‡a  regulationofcytochromep450byinflammatorymediatorswhyandhow‏ ‎‡A  Regulation of cytochrome p450 by inflammatory mediators: why and how?‏ ‎‡9  1‏
919 ‎‡a  regulationofcytochromep4502c11cyp2c11geneexpressionbyinterleukin1sphingomyelinhydrolysisandceramidesinrathepatocytes‏ ‎‡A  Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes‏ ‎‡9  1‏
919 ‎‡a  rapidtranscriptionalsuppressionofratcytochromep450genesbyendotoxintreatmentanditsinhibitionbycurcumin‏ ‎‡A  Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin.‏ ‎‡9  1‏
919 ‎‡a  purificationofadesmethylimipramineanddebrisoquinehydroxylatingcytochromep450fromhumanliver‏ ‎‡A  Purification of a desmethylimipramine and debrisoquine hydroxylating cytochrome P-450 from human liver‏ ‎‡9  1‏
919 ‎‡a  purificationcharacterizationandpituitaryregulationofthesexspecificcytochromep45015betahydroxylasefromlivermicrosomesofuntreatedfemalerats‏ ‎‡A  Purification, characterization, and pituitary regulation of the sex-specific cytochrome P-450 15 beta-hydroxylase from liver microsomes of untreated female rats.‏ ‎‡9  1‏
919 ‎‡a  purificationandcharacterizationofauniqueisozymeofcytochromep450fromlivermicrosomesofethanoltreatedrabbits‏ ‎‡A  Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits‏ ‎‡9  1‏
919 ‎‡a  pretranslationalsuppressionofcytochromep450hiic11geneexpressioninratliverafteradministrationofinterferoninducers‏ ‎‡A  Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in rat liver after administration of interferon inducers‏ ‎‡9  1‏
919 ‎‡a  pretranslationalsuppressionofcytochromep450h‏ ‎‡A  Pretranslational suppression of cytochrome P-450h‏ ‎‡9  1‏
919 ‎‡a  pretranslationalinductionofcyp4asubfamilygeneproductsindiabeticratsandreversalbyoralvanadatetreatment‏ ‎‡A  Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment‏ ‎‡9  1‏
919 ‎‡a  preparationandcharacterizationofmonoclonalantibodiesrecognizinguniqueepitopesonsexuallydifferentiatedratlivercytochromep450isozymes‏ ‎‡A  Preparation and characterization of monoclonal antibodies recognizing unique epitopes on sexually differentiated rat liver cytochrome P-450 isozymes‏ ‎‡9  1‏
919 ‎‡a  physiologicalregulationofdrugmetabolismandtransportpregnancymicrobiomeinflammationinfectionandfasting‏ ‎‡A  Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting‏ ‎‡9  1‏
919 ‎‡a  physiologicalandpathophysiologicalregulationofcytochromep450‏ ‎‡A  Physiological and pathophysiological regulation of cytochrome P450.‏ ‎‡9  1‏
919 ‎‡a  oxidationoftricyclicantidepressantdrugsdebrisoquineand7ethoxyresorufinbyhumanliverpreparations‏ ‎‡A  Oxidation of tricyclic antidepressant drugs, debrisoquine and 7-ethoxyresorufin, by human liver preparations‏ ‎‡9  1‏
919 ‎‡a  nitricoxidemediateddegradationofcyp2a6viatheubiquitinproteasomepathwayinhumanhepatomacells‏ ‎‡A  Nitric Oxide Mediated Degradation of CYP2A6 via the Ubiquitin-Proteasome Pathway in Human Hepatoma Cells‏ ‎‡9  1‏
919 ‎‡a  nitricoxideindependentsuppressionofp4502c11expressionbyinterleukin1betaandendotoxininprimaryrathepatocytes‏ ‎‡A  Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes‏ ‎‡9  1‏
919 ‎‡a  nitricoxidedependentproteasomaldegradationofcytochromep4502bproteins‏ ‎‡A  Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins‏ ‎‡9  1‏
919 ‎‡a  nitricoxidedependentcyp2bdegradationispotentiatedbyacytokineregulatedpathwayandutilizestheimmunoproteasomesubunitlmp2‏ ‎‡A  Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2‏ ‎‡9  1‏
919 ‎‡a  nitricoxideandinterleukin1βstimulatetheproteasomeindependentdegradationoftheretinoicacidhydroxylasecyp2c22inprimaryrathepatocytes‏ ‎‡A  Nitric oxide and interleukin-1β stimulate the proteasome-independent degradation of the retinoic acid hydroxylase CYP2C22 in primary rat hepatocytes.‏ ‎‡9  1‏
919 ‎‡a  molecularcloningandregulationofexpressionof2novelmousecyp4fgenesexpressioninperoxisomeproliferatoractivatedreceptoralphadeficientmiceuponlipopolysaccharideandclofibratechallenges‏ ‎‡A  Molecular cloning and regulation of expression of two novel mouse CYP4F genes: expression in peroxisome proliferator-activated receptor alpha-deficient mice upon lipopolysaccharide and clofibrate challenges‏ ‎‡9  1‏
919 ‎‡a  modulationofdrugmetabolismininfectiousandinflammatorydiseases‏ ‎‡A  Modulation of drug metabolism in infectious and inflammatory diseases‏ ‎‡9  1‏
919 ‎‡a  modulationofcytochromep450geneexpressioninendotoxemicmiceistissuespecificandperoxisomeproliferatoractivatedreceptoralphadependent‏ ‎‡A  Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent‏ ‎‡9  1‏
919 ‎‡a  metabolomicsrevealsthathepaticstearoylcoadesaturase1downregulationexacerbatesinflammationandacutecolitis‏ ‎‡A  Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis‏ ‎‡9  1‏
919 ‎‡a  metabolismandactionofproteasomeinhibitorsinprimaryhumanhepatocytes‏ ‎‡A  Metabolism and action of proteasome inhibitors in primary human hepatocytes‏ ‎‡9  1‏
919 ‎‡a  mechanismsofcytochromep450regulationbyinflammatorymediators‏ ‎‡A  Mechanisms of cytochrome P450 regulation by inflammatory mediators.‏ ‎‡9  1‏
919 ‎‡a  inhibitionofestrogeninducedmammarytumorformationinmmtvaromatasetransgenicmiceby4chlorophenylacetate‏ ‎‡A  Inhibition of estrogen-induced mammary tumor formation in MMTV-aromatase transgenic mice by 4-chlorophenylacetate.‏ ‎‡9  1‏
919 ‎‡a  inflammatorypromptsproduceisoformspecificchangesintheexpressionofleukotrieneb4omegahydroxylasesinratliverandkidney‏ ‎‡A  Inflammatory prompts produce isoform-specific changes in the expression of leukotriene B(4) omega-hydroxylases in rat liver and kidney.‏ ‎‡9  1‏
919 ‎‡a  inflammatorypromptsproduceisoformspecificchangesintheexpressionofleukotrieneb‏ ‎‡A  Inflammatory prompts produce isoform-specific changes in the expression of leukotriene B‏ ‎‡9  1‏
919 ‎‡a  impactofinfectiousandinflammatorydiseaseoncytochromep450mediateddrugmetabolismandpharmacokinetics‏ ‎‡A  Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics‏ ‎‡9  1‏
919 ‎‡a  hormonalanddevelopmentalregulationofexpressionofthehepaticmicrosomalsteroid16alphahydroxylasecytochromep450apoproteinintherat‏ ‎‡A  Hormonal and developmental regulation of expression of the hepatic microsomal steroid 16 alpha-hydroxylase cytochrome P-450 apoprotein in the rat‏ ‎‡9  1‏
919 ‎‡a  hepaticflavincontainingmonooxygenasegeneregulationindifferentmouseinflammationmodels‏ ‎‡A  Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models.‏ ‎‡9  1‏
919 ‎‡a  hepaticcytochromep450sphase2enzymesandnuclearreceptorsaredownregulatedinath2environmentduringschistosomamansoniinfection‏ ‎‡A  Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection.‏ ‎‡9  1‏
919 ‎‡a  hepaticcytochromep450regulationindiseasestates‏ ‎‡A  Hepatic cytochrome P450 regulation in disease states‏ ‎‡9  1‏
919 ‎‡a  hepaticandrenalcytochromep450generegulationduringcitrobacterrodentiuminfectioninwildtypeandtolllikereceptor4mutantmice‏ ‎‡A  Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice.‏ ‎‡9  1‏
919 ‎‡a  growthhormoneregulatesexpressionofratlivercytochromep45015betaatapretranslationallevel‏ ‎‡A  Growth hormone regulates expression of rat liver cytochrome P-450 15 beta at a pretranslational level‏ ‎‡9  1‏
919 ‎‡a  growthhormonedependentandindependentregulationofcytochromep450isozymeexpressioninstreptozotocindiabeticrats‏ ‎‡A  Growth hormone-dependent and -independent regulation of cytochrome P-450 isozyme expression in streptozotocin-diabetic rats‏ ‎‡9  1‏
919 ‎‡a  genespecificeffectsofinflammatorycytokinesoncytochromep4502c2b6and3a4mrnalevelsinhumanhepatocytes‏ ‎‡A  Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes.‏ ‎‡9  1‏
919 ‎‡a  expressionofudpglucuronosyltransferaseisoformmrnasduringinflammationandinfectioninmouseliverandkidney‏ ‎‡A  Expression of UDP-glucuronosyltransferase isoform mRNAs during inflammation and infection in mouse liver and kidney‏ ‎‡9  1‏
919 ‎‡a  endotoxemiainratsisassociatedwithinductionofthep4504asubfamilyandsuppressionofseveralotherformsofcytochromep450‏ ‎‡A  Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450.‏ ‎‡9  1‏
919 ‎‡a  effectsofvanadateonhepaticcytochromep450expressioninstreptozotocindiabeticrats‏ ‎‡A  Effects of vanadate on hepatic cytochrome P-450 expression in streptozotocin-diabetic rats.‏ ‎‡9  1‏
919 ‎‡a  effectsofearlymaternalseparationonethanolintakegabareceptorsandmetabolizingenzymesinadultrats‏ ‎‡A  Effects of early maternal separation on ethanol intake, GABA receptors and metabolizing enzymes in adult rats.‏ ‎‡9  1‏
919 ‎‡a  effectsofcytochromeb5oncytochromep450catalyzedreactionsstudieswithmanganesesubstitutedcytochromeb5‏ ‎‡A  Effects of cytochrome b5 on cytochrome P-450-catalyzed reactions. Studies with manganese-substituted cytochrome b5‏ ‎‡9  1‏
919 ‎‡a  effectsofbacteriallipopolysaccharideonphenobarbitalinducedcyp2bexpressioninmice‏ ‎‡A  Effects of bacterial lipopolysaccharide on phenobarbital-induced CYP2B expression in mice‏ ‎‡9  1‏
919 ‎‡a  dualmechanismsofcyp3aproteinregulationbyproinflammatorycytokinestimulationinprimaryhepatocytecultures‏ ‎‡A  Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures.‏ ‎‡9  1‏
919 ‎‡a  downregulationoftheexpressionof3majorratlivercytochromep450sbyendotoxininvivooccursindependentlyofnitricoxideproduction‏ ‎‡A  Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production‏ ‎‡9  1‏
919 ‎‡a  downregulationofphenobarbitalinducedcytochromep4502bmrnasandproteinsbyendotoxininmiceindependencefromnitricoxideproductionbyinduciblenitricoxidesynthase‏ ‎‡A  Down-regulation of phenobarbital-induced cytochrome P4502B mRNAs and proteins by endotoxin in mice: independence from nitric oxide production by inducible nitric oxide synthase‏ ‎‡9  1‏
919 ‎‡a  downregulationofmultiplecytochromep450geneproductsbyinflammatorymediatorsinvivoindependencefromthehypothalamopituitaryaxis‏ ‎‡A  Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Independence from the hypothalamo-pituitary axis‏ ‎‡9  1‏
919 ‎‡a  nonlethalmalarialinfectionresultsinreduceddrugmetabolizingenzymeexpressionanddrugclearanceinmice‏ ‎‡A  A non-lethal malarial infection results in reduced drug metabolizing enzyme expression and drug clearance in mice‏ ‎‡9  1‏
919 ‎‡a  rolefor1ormorep450enzymesintheresponsetosepsis‏ ‎‡A  A role for one or more p450 enzymes in the response to sepsis.‏ ‎‡9  1‏
919 ‎‡a  differentialinductiveandsuppressiveeffectsofendotoxinandparticulateirritantsonhepaticandrenalcytochromep450expression‏ ‎‡A  Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression‏ ‎‡9  1‏
919 ‎‡a  differencesinglycogenlipidsandenzymesinliversfromratsflownoncosmos‏ ‎‡A  Differences in glycogen, lipids, and enzymes in livers from rats flown on COSMOS 2044‏ ‎‡9  1‏
919 ‎‡a  cytochromesp450andflavinmonooxygenasestargetsandsourcesofnitricoxide‏ ‎‡A  Cytochromes P450 and flavin monooxygenases--targets and sources of nitric oxide.‏ ‎‡9  1‏
919 ‎‡a  comparisonof6rabbitlivercytochromep450isozymesinformationofareactivemetaboliteofacetaminophen‏ ‎‡A  Comparison of six rabbit liver cytochrome P-450 isozymes in formation of a reactive metabolite of acetaminophen‏ ‎‡9  1‏
919 ‎‡a  characterizationofcyp4ainductioninratliverbyinflammatorystimulidependenceonsexstrainandinflammationevokedhypophagia‏ ‎‡A  Characterization of CYP4A induction in rat liver by inflammatory stimuli: dependence on sex, strain, and inflammation-evoked hypophagia.‏ ‎‡9  1‏
919 ‎‡a  alcoholoxidationbyisozyme3aoflivermicrosomalcytochromep450‏ ‎‡A  Alcohol oxidation by isozyme 3a of liver microsomal cytochrome P-450‏ ‎‡9  1‏
919 ‎‡a  alteredinflammatoryresponsestocitrobacterrodentiuminfectionbutnotbacteriallipopolysaccharideinmicelackingthecyp4a10orcyp4a14genes‏ ‎‡A  Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes‏ ‎‡9  1‏
919 ‎‡a  cancerinflammationandtherapyeffectsoncytochromep450mediateddrugmetabolismandimplicationsfornovelimmunotherapeuticagents‏ ‎‡A  Cancer, inflammation, and therapy: effects on cytochrome p450-mediated drug metabolism and implications for novel immunotherapeutic agents.‏ ‎‡9  1‏
943 ‎‡a  204x‏ ‎‡A  2044‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  LC|n 82079489‏
996 ‎‡2  LC|n 50039058‏
996 ‎‡2  ISNI|0000000038465277‏
996 ‎‡2  NII|DA02252423‏
996 ‎‡2  ISNI|0000000046222224‏
996 ‎‡2  J9U|987007463643505171‏
996 ‎‡2  LC|no2006016673‏
996 ‎‡2  LC|nr 93026756‏
996 ‎‡2  ISNI|0000000114743161‏
996 ‎‡2  PTBNP|1788569‏
996 ‎‡2  NUKAT|n 98021575‏
996 ‎‡2  LIH|LNB:CA_u__a_;=B_q_‏
996 ‎‡2  BNC|981058522372706706‏
996 ‎‡2  LC|no2006128307‏
996 ‎‡2  DNB|128445149‏
996 ‎‡2  ISNI|0000000108925516‏
996 ‎‡2  DNB|1089437455‏
996 ‎‡2  SUDOC|275326411‏
996 ‎‡2  NTA|06762281X‏
996 ‎‡2  LC|n 97007687‏
996 ‎‡2  DNB|134112024‏
996 ‎‡2  LC|no2008167918‏
996 ‎‡2  NLA|000035362163‏
996 ‎‡2  NLA|000035362165‏
996 ‎‡2  NDL|00515125‏
996 ‎‡2  PLWABN|9810557692205606‏
996 ‎‡2  BIBSYS|90219187‏
996 ‎‡2  JPG|500025899‏
996 ‎‡2  ISNI|0000000054333768‏
996 ‎‡2  SUDOC|067720471‏
996 ‎‡2  NLA|000036001208‏
996 ‎‡2  BIBSYS|90530830‏
996 ‎‡2  LC|n 88646916‏
996 ‎‡2  SUDOC|158738853‏
996 ‎‡2  ISNI|000000036947811X‏
996 ‎‡2  LC|n 2004153543‏
996 ‎‡2  NLA|000035952021‏
996 ‎‡2  J9U|987007376527605171‏
996 ‎‡2  LC|n 2012183840‏
996 ‎‡2  LC|nb2019021080‏
996 ‎‡2  LC|nb2006015569‏
996 ‎‡2  ISNI|0000000067881915‏
996 ‎‡2  SUDOC|032407645‏
996 ‎‡2  LC|no2010147608‏
996 ‎‡2  BNF|12480879‏
996 ‎‡2  NUKAT|n 2017008014‏
996 ‎‡2  LC|no 00062865‏
996 ‎‡2  LC|no2010152991‏
996 ‎‡2  BNF|12344334‏
996 ‎‡2  NII|DA04535043‏
996 ‎‡2  NII|DA00376232‏
996 ‎‡2  NII|DA00613939‏
996 ‎‡2  J9U|987007398441905171‏
996 ‎‡2  NKC|vse2005299814‏
996 ‎‡2  NII|DA05758724‏
996 ‎‡2  ISNI|0000000437589365‏
996 ‎‡2  RERO|A006448593‏
996 ‎‡2  NUKAT|n 2019013208‏
996 ‎‡2  NII|DA01694914‏
996 ‎‡2  J9U|987007324615405171‏
996 ‎‡2  CAOONL|ncf11261769‏
996 ‎‡2  ISNI|0000000067112147‏
996 ‎‡2  NTA|317228838‏
996 ‎‡2  NTA|315722762‏
996 ‎‡2  LNB|LNC10-000201828‏
996 ‎‡2  N6I|vtls000285565‏
996 ‎‡2  RERO|A003609446‏
996 ‎‡2  ISNI|0000000121323229‏
996 ‎‡2  JPG|500447619‏
996 ‎‡2  LC|n 97850223‏
996 ‎‡2  LC|no2023029233‏
996 ‎‡2  LC|n 50005850‏
996 ‎‡2  RERO|A003609449‏
996 ‎‡2  RERO|A003609448‏
996 ‎‡2  NTA|130278750‏
996 ‎‡2  BNE|XX6017475‏
996 ‎‡2  UIY|000087041‏
996 ‎‡2  SUDOC|08696951X‏
996 ‎‡2  PTBNP|1572216‏
996 ‎‡2  NTA|331375974‏
996 ‎‡2  SUDOC|032612087‏
996 ‎‡2  EGAXA|vtls002680585‏
996 ‎‡2  DNB|1246249669‏
996 ‎‡2  LNB|LNC10-000065690‏
996 ‎‡2  LC|n 90666861‏
996 ‎‡2  N6I|vtls000013542‏
996 ‎‡2  JPG|500167689‏
996 ‎‡2  SUDOC|076055523‏
996 ‎‡2  ISNI|0000000108164999‏
996 ‎‡2  J9U|987007424356905171‏
996 ‎‡2  ISNI|0000000116652706‏
996 ‎‡2  ISNI|0000000082244228‏
996 ‎‡2  DNB|1056528834‏
996 ‎‡2  NUKAT|n 01717709‏
996 ‎‡2  BIBSYS|90053287‏
996 ‎‡2  LC|n 50005824‏
996 ‎‡2  ISNI|0000000035399593‏
996 ‎‡2  NUKAT|n 99091662‏
996 ‎‡2  SIMACOB|55430755‏
996 ‎‡2  NTA|067626610‏
996 ‎‡2  ISNI|0000000053741460‏
996 ‎‡2  SELIBR|242013‏
996 ‎‡2  DNB|1223623416‏
996 ‎‡2  RERO|A003609450‏
996 ‎‡2  LC|n 85195731‏
996 ‎‡2  LC|n 50005822‏
996 ‎‡2  LC|n 50005823‏
996 ‎‡2  J9U|987007463643305171‏
996 ‎‡2  NUKAT|n 2009111623‏
996 ‎‡2  J9U|987007290170605171‏
996 ‎‡2  DNB|143384309‏
996 ‎‡2  LC|n 82258419‏
996 ‎‡2  LC|n 2012006647‏
996 ‎‡2  DNB|118996053‏
996 ‎‡2  LC|n 50005821‏
996 ‎‡2  J9U|987012858834905171‏
996 ‎‡2  SUDOC|133979989‏
996 ‎‡2  LC|n 2019007715‏
996 ‎‡2  ISNI|0000000382998822‏
996 ‎‡2  J9U|987007271579705171‏
996 ‎‡2  SELIBR|287096‏
996 ‎‡2  LC|nr 89007206‏
996 ‎‡2  ISNI|0000000063276996‏
996 ‎‡2  LC|n 90669299‏
996 ‎‡2  BLBNB|001433904‏
996 ‎‡2  ISNI|0000000398471777‏
996 ‎‡2  BNF|16248455‏
996 ‎‡2  BIBSYS|90090616‏
996 ‎‡2  BAV|495_346947‏
996 ‎‡2  ISNI|0000000039654205‏
996 ‎‡2  RERO|A022957749‏
996 ‎‡2  ISNI|0000000042107579‏
996 ‎‡2  ISNI|0000000383684745‏
996 ‎‡2  JPG|500460860‏
996 ‎‡2  CAOONL|ncf11214118‏
996 ‎‡2  NII|DA02393447‏
996 ‎‡2  KRNLK|KAC200703849‏
996 ‎‡2  NII|DA03982501‏
996 ‎‡2  BNF|12163094‏
996 ‎‡2  LIH|LNB:OYE;=BJ‏
996 ‎‡2  NLA|000035362166‏
996 ‎‡2  N6I|vtls000045442‏
996 ‎‡2  LC|nr 93009207‏
996 ‎‡2  DNB|133479943‏
996 ‎‡2  LC|n 97004750‏
996 ‎‡2  CAOONL|ncf10101966‏
996 ‎‡2  DNB|132982854‏
996 ‎‡2  ISNI|0000000025291853‏
996 ‎‡2  BIBSYS|7068051‏
996 ‎‡2  ISNI|0000000385936774‏
996 ‎‡2  NTA|070206813‏
996 ‎‡2  ISNI|0000000051336752‏
996 ‎‡2  DNB|1188360094‏
996 ‎‡2  RERO|A016735241‏
996 ‎‡2  LC|n 85817484‏
996 ‎‡2  BIBSYS|11073302‏
996 ‎‡2  BAV|495_64299‏
996 ‎‡2  BAV|495_64298‏
996 ‎‡2  ISNI|0000000399438469‏
996 ‎‡2  N6I|vtls000275588‏
996 ‎‡2  BNF|18059191‏
996 ‎‡2  J9U|987007265530305171‏
996 ‎‡2  PLWABN|9810566307305606‏
996 ‎‡2  LC|no 00024472‏
996 ‎‡2  ISNI|0000000108850630‏
996 ‎‡2  ISNI|0000000081666955‏
996 ‎‡2  BAV|495_219447‏
996 ‎‡2  DNB|1017063990‏
996 ‎‡2  BIBSYS|90649996‏
996 ‎‡2  ISNI|0000000049594728‏
996 ‎‡2  PLWABN|9810578030805606‏
996 ‎‡2  ICCU|UBOV515646‏
996 ‎‡2  DNB|117601535‏
996 ‎‡2  NUKAT|n 2011061609‏
996 ‎‡2  BIBSYS|4084728‏
996 ‎‡2  NLA|000035989467‏
996 ‎‡2  NLA|000035351880‏
996 ‎‡2  ISNI|000000002820513X‏
996 ‎‡2  ISNI|0000000495802136‏
996 ‎‡2  LNB|LNC10-000032396‏
996 ‎‡2  DNB|1314086324‏
996 ‎‡2  SUDOC|032872763‏
996 ‎‡2  ISNI|0000000044461731‏
996 ‎‡2  NLA|000035773880‏
996 ‎‡2  NUKAT|n 97039227‏
996 ‎‡2  NII|DA19290835‏
996 ‎‡2  LC|n 84173201‏
996 ‎‡2  NII|DA06440287‏
996 ‎‡2  NTA|126811725‏
996 ‎‡2  NKC|utb2015875690‏
996 ‎‡2  SUDOC|030158230‏
996 ‎‡2  LC|n 90684831‏
996 ‎‡2  J9U|987007362620105171‏
996 ‎‡2  LC|no2007016903‏
996 ‎‡2  LC|n 89613931‏
996 ‎‡2  CAOONL|ncf11158534‏
996 ‎‡2  RERO|A024488860‏
996 ‎‡2  BIBSYS|90526923‏
996 ‎‡2  NDL|00524558‏
996 ‎‡2  LC|n 86144576‏
996 ‎‡2  NDL|00450501‏
996 ‎‡2  NUKAT|n 2019002130‏
996 ‎‡2  NDL|00450502‏
996 ‎‡2  ISNI|0000000049284543‏
996 ‎‡2  LC|n 78075004‏
996 ‎‡2  LC|no2009193157‏
996 ‎‡2  SUDOC|154770329‏
996 ‎‡2  LC|no 99067032‏
996 ‎‡2  CAOONL|ncf10263628‏
996 ‎‡2  LIH|LNB:V-375889;=B_a_‏
996 ‎‡2  J9U|987007463643405171‏
996 ‎‡2  RERO|A014286428‏
996 ‎‡2  CAOONL|ncf12148245‏
996 ‎‡2  NYNYRILM|214728‏
996 ‎‡2  ISNI|0000000034350325‏
996 ‎‡2  LC|nr2001052811‏
996 ‎‡2  LC|no2012152470‏
996 ‎‡2  DNB|1146424183‏
996 ‎‡2  BNC|981058530579606706‏
996 ‎‡2  NII|DA10042776‏
996 ‎‡2  SKMASNL|vtls011364963‏
996 ‎‡2  J9U|987007343014405171‏
996 ‎‡2  NTA|27442617X‏
996 ‎‡2  NYNYRILM|68174‏
996 ‎‡2  NSK|000161678‏
996 ‎‡2  BIBSYS|10008743‏
996 ‎‡2  RERO|A028121485‏
996 ‎‡2  LC|no2001050466‏
996 ‎‡2  SUDOC|199415544‏
996 ‎‡2  BNF|12360861‏
996 ‎‡2  LC|n 2005011864‏
996 ‎‡2  NUKAT|n 2013188767‏
996 ‎‡2  CAOONL|ncf12112089‏
996 ‎‡2  ISNI|0000000396612302‏
996 ‎‡2  DNB|131921665‏
996 ‎‡2  NTA|067622844‏
996 ‎‡2  NTA|067618103‏
996 ‎‡2  LC|no2020090183‏
996 ‎‡2  N6I|vtls001315542‏
996 ‎‡2  ISNI|0000000038956885‏
996 ‎‡2  ISNI|0000000116769090‏
996 ‎‡2  BNF|12381812‏
996 ‎‡2  LC|no 00026328‏
996 ‎‡2  RERO|A003609445‏
996 ‎‡2  LC|n 2002126007‏
996 ‎‡2  ISNI|000000003953908X‏
996 ‎‡2  NTA|328245151‏
996 ‎‡2  DNB|1186173327‏
996 ‎‡2  BNF|10553381‏
996 ‎‡2  NKC|xx0006398‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏